Home
This Title All WIREs
WIREs RSS Feed
How to cite this WIREs title:
WIREs Syst Biol Med
Impact Factor: 2.385

Engineered tissue grafts: opportunities and challenges in regenerative medicine

Full article on Wiley Online Library:   HTML PDF

Can't access this content? Tell your librarian.

The human body has limited regenerative capacity in most of the major tissues and organs. This fact has spurred the field of regenerative medicine, promising to repair damage following traumatic injury or disease. Multiple therapeutic strategies are being explored including small molecules, gene delivery, and stem cells; however, tissue engineering remains a primary approach to achieving regeneration. Organ transplantation demonstrates that damaged tissues can be replaced, but technology to regenerate complex organs de novo is not yet available. Instead, tissue engineering can augment the body's own regenerative ability by replacing tissue sections and enhancing the regenerative cascade. As a consequence of these opportunities, it is timely to review the criteria and current status of engineered tissue grafts designed as patches to replace or regenerate damaged or diseased tissue and restore organ function. This topic will be explored starting from the biomaterials and cells incorporated into the engineered graft, the environment into which the graft is implanted and the integration of the engineered graft with the host. Common issues will be addressed that are relevant to regeneration in multiple tissue and organ systems. Specific examples will focus on engineered grafts for myocardial and corneal repair to illustrate the tissue‐specific challenges and opportunities and highlight the innovation needed as the field moves forward. WIREs Syst Biol Med 2012, 4:207–220. doi: 10.1002/wsbm.164

This WIREs title offers downloadable PowerPoint presentations of figures for non-profit, educational use, provided the content is not modified and full credit is given to the author and publication.

Download a PowerPoint presentation of all images


Figure 1.

Schematic of the basic approach used to create an engineered tissue graft for regenerative medicine applications. Briefly, a biomaterial scaffold is seeded with cells and placed into a bioreactor to stimulate differentiation, maturation, and growth of the cells into a functional construct. Ideally, a combination of contractility, electrophysiology, gene expression, and structure are used as readouts to optimize the bioreactor design and improve tissue function. The engineered tissue graft is then implanted and undergoes integration with the host tissue, which may involve vascularization and innervation depending on the tissue/organ type. Alternatively, the biomaterial scaffold may be implanted as an acellular construct and recruit endogenous cells in vivo. Example applications of the engineered tissue graft include cardiac, skeletal, ophthalmic, vascular, and neural regeneration.

[ Normal View | Magnified View ]

Related Articles

Mesenchymal stem cell differentiation and roles in regenerative medicine
Biophysics and dynamics of natural and engineered stem cell microenvironments
Cardiac lineage selection: integrating biological complexity into computational models
Stem Cells: A Systems Approach

Browse by Topic

Developmental Biology > Stem Cell Biology and Regeneration
Translational, Genomic, and Systems Medicine > Translational Medicine
Translational, Genomic, and Systems Medicine > Therapeutic Methods

Access to this WIREs title is by subscription only.

Recommend to Your
Librarian Now!

The latest WIREs articles in your inbox

Sign Up for Article Alerts

In the Spotlight

Jens Nielsen

Jens Nielsen
is a Professor in the Department of Biology and Biological Engineering at Chalmers University of Technology in Göteborg, Sweden. His research focus is on systems biology of metabolism. The yeast Saccharomyces cerevisiae is the lab’s key organism for experimental research, but they also work with Aspergilli oryzae.

Learn More